No but you can email investor relations and Dean will likely reply. I actually think AASB standards might prohibit you from full expensing that much R and D? But I could be wrong there.
He said most companies will also bring R and D tax credits in the year of receipt but they also don’t do this so the policy is aligned and they also amortise that. if anything the company would benefit from fully expensing R and D so it’s gone and then they can report higher profits in the next few years.
Ann: Beam Investor Presentation - March 2022, page-21
Add BCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.015(11.1%) |
Mkt cap ! $12.53M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 15.0¢ | 14.0¢ | $14.33K | 99.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 677 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 22203 | 3 |
View Market Depth
| Last trade - 11.10am 05/06/2024 (20 minute delay) ? |
| BCC (ASX) Chart |